Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ENB003 |
Synonyms | |
Therapy Description |
ENB003 is an an antagonist that selectively binds to endothelin B receptor (ETBR) and inhibits downstream signaling, which potentially relieves tumor immunosuppression and inhibits proliferation of tumor cells expressing ETBR (Clin Cancer Res 2009;15(14):4521-4528; NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ENB003 | ENB-003|ENB 003|Vodudeutentan Sodium | ENB003 is an an antagonist that selectively binds to endothelin B receptor (ETBR) and inhibits downstream signaling, which potentially relieves tumor immunosuppression and inhibits proliferation of tumor cells expressing ETBR (Clin Cancer Res 2009;15(14):4521-4528; NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|